Associated Papers
Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Sensitive Response to Afatinib: A Case Report and Literature Review.
Chen S et al.
Lung Cancer (auckland, N.z.), 2025
Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC.
Wang J et al.
International Journal of Cancer, 2019
Select a paper to view details